Clinical Trial Imaging Services Procurement Intelligence Report, 2023 - 2030
Clinical Trial Imaging Services Procurement Intelligence The clinical trial imaging services category is anticipated to grow at a CAGR of 8.05% from 2023 to 2030. North America holds the largest category share at about 41%. The rising number of Contract Research Organizations (CROs) along with biotechnology and pharmaceutical companies, the increasing presence of chronic health diseases among the population, the development of innovative imaging techniques, and rising R&D investment to develop new drugs and therapies are some of the key factors driving the growth. Order your copy of the Clinical Trial Imaging Services category procurement intelligence report 2023-2030 , published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis Clinical Trial Imaging Services Procurement Intelligence Report Scope The Clinical Trial Imaging Services categor...